Progyny, Inc. (PGNY)
Progyny, Inc. (PGNY) from its SEC filings: 2025 revenue $1.3 billion (+10% vs the year before), net margin 4%, free cash flow $191.8 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Misc Health & Allied Services, Nec |
| Revenue (2025) | $1.3 billion |
| Revenue growth | +10% |
| Net income | $58.5 million |
| Net margin | 4.5% |
| Free cash flow | $191.8 million |
| Diluted EPS | $0.65 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +5% |
| Cash | $152.6 million |
| Share count, 1 year | -11% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.